Page last updated: 2024-09-04

canertinib and Alopecia Cicatrisata

canertinib has been researched along with Alopecia Cicatrisata in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, AP; Courtney, CL; Criswell, KA; Dunstan, RW; Graziano, MJ	1

Other Studies

1 other study(ies) available for canertinib and Alopecia Cicatrisata

Article	Year
Cutaneous lesions in the rat following administration of an irreversible inhibitor of erbB receptors, including the epidermal growth factor receptor. Toxicologic pathology, 2008, Volume: 36, Issue:3 Topics: Administration, Oral; Alopecia; Animals; Area Under Curve; Dose-Response Relationship, Drug; ErbB Receptors; Female; Folliculitis; Longevity; Male; Morpholines; Rats; Rats, Wistar; Receptor Protein-Tyrosine Kinases; Skin; Skin Diseases, Papulosquamous; Toxicity Tests	2008

Article

Year

Cutaneous lesions in the rat following administration of an irreversible inhibitor of erbB receptors, including the epidermal growth factor receptor.

Toxicologic pathology, 2008, Volume: 36, Issue:3

Topics: Administration, Oral; Alopecia; Animals; Area Under Curve; Dose-Response Relationship, Drug; ErbB Receptors; Female; Folliculitis; Longevity; Male; Morpholines; Rats; Rats, Wistar; Receptor Protein-Tyrosine Kinases; Skin; Skin Diseases, Papulosquamous; Toxicity Tests

2008